CataloniaBio & HealthTech held its general assembly on 14 February at the Ateneu Barcelonès, where the members of the board, the executive team and around a hundred members met to discuss and approve the management report and accounts for the 2023 financial year, as well as the action plan for 2024. It also approved the admission of 36 new members, who had the opportunity to present themselves before the attendees.

Mariona Serra (president), Joan Puig (vice-president), Nuria Pastor (secretary), and Javier Selva (CEO) spoke on behalf of the board to explain the different points. At the strategic level, the new initiatives promoted and carried out last year were reviewed, as well as all the new initiatives and those that need  to be consolidated in 2024. In particular, the new Strategic Plan 2024-26 was presented: what the process has been, the different actors involved, how it has been drafted and what are the guidelines for the coming years for the association.

New members and ratification of Boardchanges

In 2023, 36 new members joined CataloniaBio & HealthTech, including companies and institutions that represent the health sector in a transversal way, as well as representing the whole territory. All those who were able to attend were able to introduce themselves to the audience.

It was also presented for the ratification of the members the changes in the members and members of the Board of Directors. The most remarkable is the exchange of positions between Mariona Serra, Founder and Director of GoodGut (Grup HIPRA), and Joan Puig, CEO of Kymos. Both led the candidacy presented two years ago, which foresaw the change in the presidency in the middle of the term, in accordance with the Statutes of the association. In addition to the change of leadership on the Board, four of the Board's memberships have been renewed, as also provided forin the Bylaws. Marta Parente (GP Pharm), Joël Jean-Mairet (Ysios Capital Partners), Elisabeth Stampa (Medichem) and Jordi Barretina (Germans Trias i Pujol Research Institute - IGTP) will replace Carmen Lagunas (Ferrer), Begoña Benito (Vall d'Hebron Research Institute - VHIR), Marta Palicio (Werfen) and Adriana Carré (Inteplast Medical), the latter two will remain linked tothe Board as permanent observers for the next two years.